大家说说这个什么时_老虎社区_美港股上老虎 - 老虎社区

点赞
评论
收藏

m李木子
09-05

大家说说这个什么时候上升期间 😥

港股异动 | 瑞科生物-B(02179)午前跌超15% 创上市新低中信近日下调公司收入预测及目标价

智通财经APP获悉，瑞科生物-B(02179)午前跌超15%，低见11.9港元，创上市新低。截至发稿，跌15%，报11.9港元，成交额1772.6万港元。中信证券近日表示，将瑞科生物目标价由34港元大幅下调至21港元，维持“买入”评级。该行指，由于新冠防控政策调整使得新冠疫苗接种需求下降，且新冠疫苗价格降幅和竞争加剧超出预期，该行调整公司2023/24年营业收入预测为0/4000万元，原预测为8000万/1.2亿元。

港股异动 | 瑞科生物-B(02179)午前跌超15% 创上市新低中信近日下调公司收入预测及目标价

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

点赞

举报

评论

推荐
最新

empty

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":345992541454632,"tweetId":"345992541454632","gmtCreate":1725497756464,"gmtModify":1725497758360,"author":{"id":3582856679212200,"idStr":"3582856679212200","authorId":3582856679212200,"authorIdStr":"3582856679212200","name":"m李木子","avatar":"https://static.tigerbbs.com/3ba1db975184a06c5905a744b90d4d34","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.13","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>大家说说 这个什么时候上升期间 😥</p></body></html>","htmlText":"<html><head></head><body><p>大家说说 这个什么时候上升期间 😥</p></body></html>","text":"大家说说 这个什么时候上升期间 😥","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/345992541454632","repostId":2337615500,"repostType":2,"repost":{"id":"2337615500","kind":"news","pubTimestamp":1684727423,"share":"https://www.laohu8.com/m/news/2337615500?lang=&edition=full","pubTime":"2023-05-22 11:50","market":"hk","language":"zh","title":"港股异动 | 瑞科生物-B(02179)午前跌超15% 创上市新低 中信近日下调公司收入预测及目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2337615500","media":"智通财经","summary":"智通财经APP获悉，瑞科生物-B(02179)午前跌超15%，低见11.9港元，创上市新低。截至发稿，跌15%，报11.9港元，成交额1772.6万港元。中信证券近日表示，将瑞科生物目标价由34港元大幅下调至21港元，维持“买入”评级。该行指，由于新冠防控政策调整使得新冠疫苗接种需求下降，且新冠疫苗价格降幅和竞争加剧超出预期，该行调整公司2023/24年营业收入预测为0/4000万元，原预测为8000万/1.2亿元。","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/02179\">瑞科生物-B</a>(02179)午前跌超15%，低见11.9港元，创上市新低。截至发稿，跌15%，报11.9港元，成交额1772.6万港元。</p><p><a href=\"https://laohu8.com/S/600030\">中信证券</a>近日表示，将瑞科生物目标价由34港元大幅下调至21港元，维持“买入”评级。该行指，由于新冠防控政策调整使得新冠疫苗接种需求下降，且新冠疫苗价格降幅和竞争加剧超出预期，该行调整公司2023/24年营业收入预测为0/4000万元，原预测为8000万/1.2亿元。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 瑞科生物-B(02179)午前跌超15% 创上市新低 中信近日下调公司收入预测及目标价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 瑞科生物-B(02179)午前跌超15% 创上市新低 中信近日下调公司收入预测及目标价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-05-22 11:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/933600.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，瑞科生物-B(02179)午前跌超15%，低见11.9港元，创上市新低。截至发稿，跌15%，报11.9港元，成交额1772.6万港元。中信证券近日表示，将瑞科生物目标价由34港元大幅下调至21港元，维持“买入”评级。该行指，由于新冠防控政策调整使得新冠疫苗接种需求下降，且新冠疫苗价格降幅和竞争加剧超出预期，该行调整公司2023/24年营业收入预测为0/4000万元，原预测为...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/933600.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02179":"瑞科生物-B"},"source_url":"http://www.zhitongcaijing.com/content/detail/933600.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2337615500","content_text":"智通财经APP获悉，瑞科生物-B(02179)午前跌超15%，低见11.9港元，创上市新低。截至发稿，跌15%，报11.9港元，成交额1772.6万港元。中信证券近日表示，将瑞科生物目标价由34港元大幅下调至21港元，维持“买入”评级。该行指，由于新冠防控政策调整使得新冠疫苗接种需求下降，且新冠疫苗价格降幅和竞争加剧超出预期，该行调整公司2023/24年营业收入预测为0/4000万元，原预测为8000万/1.2亿元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":382,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":30,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}